Navigation Links
MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
Date:10/23/2008

GAITHERSBURG, Md., Oct. 23 /PRNewswire/ -- MedImmune today announced that researchers will present eight posters from its inflammatory disease program at the Annual Meeting of the American College of Rheumatology, from October 24 to 29, 2008 at the Moscone Center in San Francisco, California.

"MedImmune is working on a number of potential solutions for patients struggling with systemic autoimmune rheumatic diseases," said Barbara White, M.D., vice president, clinical development, respiratory, inflammation, and autoimmunity. "We are pleased to share promising basic research and translational science data relevant to the development of new treatments for diseases such as lupus, rheumatoid arthritis, and myositis"

MedImmune programs that will be discussed include:

-- MEDI-545 - MEDI-545 is a monoclonal antibody (MAb) targeting

interferon-alpha, which regulates processes involved in autoimmune

diseases. MedImmune has launched a broad development program with this

molecule to assess its potential to treat or prevent a variety of

immunological disorders. Currently, MedImmune is conducting a phase 2a

trial in patients with systemic lupus erythematosus (SLE) and a phase 1b

study in patients with active dermatomyositis and polymyositis. The

company has also conducted clinical trials in psoriasis with MEDI-545.

-- CAM-3001 - CAM-3001 is a MAb with potential to help patients with

rheumatoid arthritis. The antibody targets the alpha sub-unit of the

granulocyte-macrophage colony stimulating factor receptor (GM-CSFR).

CAM-3001 is a phase 1 clinical stage program.

-- ICOS - ICOS (Inducible costimulator) is a receptor on activated T-cells

that plays a central role in humoral immunity. Elevated levels of ICOS

are present in patients with autoimmune diseases and effector cytokines

have been shown to corr
'/>"/>

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
2. MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
3. MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
4. Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune
5. MedImmunes Brian Rosen Honored by Montgomery County Chamber at 49th Annual Awards Dinner
6. Depth of MedImmunes Respiratory Disease Research Program Highlighted at Annual Meeting of the American Thoracic Society
7. MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
8. MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research
9. Seneca Valley High School Student Receives Science Award From MedImmune
10. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
11. MedImmune Submits Biologics License Application to FDA for Motavizumab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015 CIRTEC Medical Systems, ... services for complex Class III implantable devices ... to develop a new 35,000 sq. ft. advanced ... has a long history of working with world’s ... breakthrough neurostimulation, heart assistance, drug delivery and smart ...
(Date:4/28/2015)... The Pistoia Alliance, a global, not-for-profit ... lower barriers to innovation in R&D, has announced the ... The Ontologies Mapping project has been set up to ... management in life sciences R&D. The project will see ... tools and services to enable the universal application of ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 According to ... than 450,000 patients receive medical treatment from burn injuries ... of burn injury, extensive formation of scars with subsequent ... burn patients for which there is no adequate treatment. ... prevent normal movement and can cause permanent deformity. ...
(Date:4/28/2015)... April 28, 2015 Reproductive endocrinologist Dr. ... in 7 couples battling infertility in this country, testified on ... Texas as the first state in the nation to consider ... embryos to couples who desire to receive them. , Infertility ... fact that infertility is one of the few medical diseases ...
Breaking Biology Technology:CIRTEC Medical Systems Expands Capacity with New Advanced Manufacturing Facility 2Pistoia Alliance Announces Start of Ontologies Mapping Project 2Synedgen Burn Treatment Results Presented at Premier Wound Conference 2Synedgen Burn Treatment Results Presented at Premier Wound Conference 3Texas Fertility Center Supports a Groundbreaking HB1145 that Facilitates Embryo Donation in Texas 2Texas Fertility Center Supports a Groundbreaking HB1145 that Facilitates Embryo Donation in Texas 3
... (Amex: CPD ) posted net sales for the ... $108.3 million, as compared to $35.4,million for the corresponding ... over the first quarter of Fiscal 2008. Pre-tax income ... 2009 as compared to a,pre-tax income of $9.6 million ...
... Inc. (Nasdaq:,INSM), a developer of follow-on biologics and ... call on Friday, August 8th at 8:30,AM ET, ... 2008. Insmed intends,to issue its quarterly financial results ... To participate in the live conference call, ...
... 24 /PRNewswire-FirstCall/ - MIGENIX Inc.,(TSX: MGI; OTC: MGIFF), ... that the directors of MIGENIX Inc. have called ... held at 2:00 p.m. (Vancouver,time) on October 31, ... Vancouver,British Columbia. Further details with respect to the ...
Cached Biology Technology:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7Insmed to Host Second Quarter 2008 Conference Call 2
(Date:4/27/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... the first week of May, 2015 and will be ... Gino Pereira , Chief Executive ... company as Wocket® enters the consumer market. We would ...
(Date:4/17/2015)... Canada , April 17, 2015 ... growing security concerns, and technological advancement to drive ... until 2020   According ... Saudi Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems ... is projected to register growth at CAGR of ...
(Date:4/10/2015)... DUBLIN , April 10, 2015 ... the addition of the "Security Competitive Profiles - ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , NEC will continue to ... solutions to the market, with a company focus on ... solution anticipated. Winning opportunities in the ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NEC Security Competitive Profile 2015 2
... (ret) Dale Meyerrose,Chief Information Officer, Office of the ... and Greg Garcia, Assistant Secretary for,Cybersecurity and Telecommunications, ... the Information Assurance community as the keynote,speaker. ... in the federal IA community has collaborated to,create ...
... this - IV (intravenous) lines in a sorghum ... one way that scientists at,the Texas Agricultural Experiment ... biofuel revolution. In Beaumont, Dr. Lee Tarpley, ... professor of crop physiology, have focused,their research on ...
... PITTSBURGH, September 12, 2007 A double amputee whose ... led to the development of new prosthetic innovations that ... the 13th annual Heinz Award for Technology, the Economy ... the world. Dr. Hugh Herr, 43, ...
Cached Biology News:Herr receives Heinz Award for Technology, the Economy and Employment 2Herr receives Heinz Award for Technology, the Economy and Employment 3Herr receives Heinz Award for Technology, the Economy and Employment 4
Rabbit Anti-Mouse Ym1 Polyclonal Antibody,...
ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
... may be carried out using this high ... System control and data processing is provided ... The elegant, powerful and very easy to use ... and 2000., The supplied automatic sample injector has ...
... This system uses the Adept CE 4100 high ... Scanning UV/Visible detector for added flexibility and utra ... trustworthy alternative to a photodiode array detection and ... detector is required for method development and for ...
Biology Products: